These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
325 related articles for article (PubMed ID: 31242575)
41. Skeletal myopathy in CKD: a comparison of adenine-induced nephropathy and 5/6 nephrectomy models in mice. Kim K; Anderson EM; Thome T; Lu G; Salyers ZR; Cort TA; O'Malley KA; Scali ST; Ryan TE Am J Physiol Renal Physiol; 2021 Jul; 321(1):F106-F119. PubMed ID: 34121452 [TBL] [Abstract][Full Text] [Related]
42. Discovery and validation of an NMR-based metabolomic profile in urine as TB biomarker. Izquierdo-Garcia JL; Comella-Del-Barrio P; Campos-Olivas R; Villar-Hernández R; Prat-Aymerich C; De Souza-Galvão ML; Jiménez-Fuentes MA; Ruiz-Manzano J; Stojanovic Z; González A; Serra-Vidal M; García-García E; Muriel-Moreno B; Millet JP; Molina-Pinargote I; Casas X; Santiago J; Sabriá F; Martos C; Herzmann C; Ruiz-Cabello J; Domínguez J Sci Rep; 2020 Dec; 10(1):22317. PubMed ID: 33339845 [TBL] [Abstract][Full Text] [Related]
43. Immune Dysfunction in Uremia 2020. Cohen G Toxins (Basel); 2020 Jul; 12(7):. PubMed ID: 32635646 [TBL] [Abstract][Full Text] [Related]
44. Roles of Nrf2 in Protecting the Kidney from Oxidative Damage. Nezu M; Suzuki N Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331329 [TBL] [Abstract][Full Text] [Related]
46. End-stage renal disease is different from chronic kidney disease in upregulating ROS-modulated proinflammatory secretome in PBMCs - A novel multiple-hit model for disease progression. Zhang R; Saredy J; Shao Y; Yao T; Liu L; Saaoud F; Yang WY; Sun Y; Johnson C; Drummer C; Fu H; Lu Y; Xu K; Liu M; Wang J; Cutler E; Yu D; Jiang X; Li Y; Li R; Wang L; Choi ET; Wang H; Yang X Redox Biol; 2020 Jul; 34():101460. PubMed ID: 32179051 [TBL] [Abstract][Full Text] [Related]
47. Mitochondria as a Source and a Target for Uremic Toxins. Popkov VA; Silachev DN; Zalevsky AO; Zorov DB; Plotnikov EY Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31242575 [TBL] [Abstract][Full Text] [Related]
48. Targeting Uremic Toxins to Prevent Peripheral Vascular Complications in Chronic Kidney Disease. Wu CL; Tarng DC Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33419312 [TBL] [Abstract][Full Text] [Related]
51. Uremic Toxins and Their Relation with Oxidative Stress Induced in Patients with CKD. Pieniazek A; Bernasinska-Slomczewska J; Gwozdzinski L Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34201270 [TBL] [Abstract][Full Text] [Related]
52. Role of Uremic Toxins in Early Vascular Ageing and Calcification. Kyriakidis NC; Cobo G; Dai L; Lindholm B; Stenvinkel P Toxins (Basel); 2021 Jan; 13(1):. PubMed ID: 33401534 [TBL] [Abstract][Full Text] [Related]
53. Neurologic conditions and disorders of uremic syndrome of chronic kidney disease: presentations, causes, and treatment strategies. Hamed SA Expert Rev Clin Pharmacol; 2019 Jan; 12(1):61-90. PubMed ID: 30501441 [No Abstract] [Full Text] [Related]
54. New approach for understanding genome variations in KEGG. Kanehisa M; Sato Y; Furumichi M; Morishima K; Tanabe M Nucleic Acids Res; 2019 Jan; 47(D1):D590-D595. PubMed ID: 30321428 [TBL] [Abstract][Full Text] [Related]